Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3588]

ASCO 2020: Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity in patients with advanced solid tumours

ASCO 2020: Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity in patients with advanced solid...

ASCO 2020: Trastuzumab combined with trimodality treatment does not improve outcomes for patients

ASCO 2020: Trastuzumab combined with trimodality treatment does not improve outcomes for patients

ASCO 2020: Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS

ASCO 2020: Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS

ASC0 2020: Study reveals factors influencing outcomes in kidney cancer treated with immunotherapy

ASC0 2020: Study reveals factors influencing outcomes in kidney cancer treated with immunotherapy

ASCO 2020: Researchers underscore efficacy of pembrolizumab plus axitinib in treating advanced renal cell carcinoma

ASCO 2020: Researchers underscore efficacy of pembrolizumab plus axitinib in treating advanced renal cell carcinoma

Study charts the immune landscape of multiple brain cancers

Study charts the immune landscape of multiple brain cancers

Mapping immune cells in brain tumours

Mapping immune cells in brain tumours

ASCO 2020: Pembrolizumab doubles time to disease progression in patients with advanced colorectal cancer with specific DNA mutations

ASCO 2020: Pembrolizumab doubles time to disease progression in patients with advanced colorectal cancer with...

New drug combinations help overcome resistance to immunotherapy

New drug combinations help overcome resistance to immunotherapy

ASCO 2020: Post-surgery osimertinib delays disease recurrence in patients with localised non-small cell lung cancer

ASCO 2020: Post-surgery osimertinib delays disease recurrence in patients with localised non-small cell lung cancer

More from ecancer